News
Director's Dealings
16 February 2015
TyraTech, Inc. (AIM: TYR and TYRU) a life sciences company focused on nature-derived insect and parasite control products, announces that, it was notified on 13 February 2015 that Mr James Hills, Non-Executive Director of the Company, bought 50,000 Common shares of US$0.001 per share (AIM: TYR) ("TyraTech shares"); at a price of 5.50 pence per TyraTech share.
Following this transaction, James Hills' interest in the Company stands at 1,240,757 TyraTech shares representing approximately 0.47% of the Company's issued share capital.
For further information please contact:
| TyraTech Inc. Bruno Jactel, Chief Executive Officer Vincent Morgus, Chief Financial Officer |
Tel: +1 919 415 4340 Tel: +1-919-415-4287 |
| SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44 203 368 3551 |
| Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: 44 20 3328 5656 |
| Whitman Howard Limited, Joint Broker Ranald McGregor-Smith/ Niall Devins |
Tel: 44 20 7087 4550 |
| Walbrook, Financial PR and IR Nick Rome/ Guy McDougall |
Tel: +44 20 7933 8792 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.